Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 31 | 2021 | 625 | 3.390 |
Why?
|
| Arthroplasty, Replacement, Hip | 25 | 2016 | 822 | 1.840 |
Why?
|
| Knee Joint | 12 | 2016 | 757 | 1.190 |
Why?
|
| Knee Prosthesis | 13 | 2021 | 223 | 1.160 |
Why?
|
| Reoperation | 29 | 2021 | 917 | 0.940 |
Why?
|
| Minimally Invasive Surgical Procedures | 7 | 2007 | 318 | 0.770 |
Why?
|
| Prosthesis Failure | 18 | 2021 | 539 | 0.690 |
Why?
|
| Tendons | 3 | 2006 | 225 | 0.630 |
Why?
|
| Patella | 6 | 2006 | 72 | 0.590 |
Why?
|
| Osteoarthritis, Knee | 5 | 2017 | 362 | 0.590 |
Why?
|
| Prosthesis Design | 17 | 2021 | 503 | 0.580 |
Why?
|
| Femur | 9 | 2010 | 400 | 0.570 |
Why?
|
| Humans | 62 | 2021 | 28573 | 0.530 |
Why?
|
| Postoperative Complications | 12 | 2021 | 934 | 0.490 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2006 | 75 | 0.480 |
Why?
|
| Range of Motion, Articular | 11 | 2016 | 725 | 0.470 |
Why?
|
| Acetabulum | 9 | 2009 | 235 | 0.470 |
Why?
|
| Tibia | 5 | 2019 | 257 | 0.440 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 35 | 0.430 |
Why?
|
| Treatment Outcome | 20 | 2016 | 3621 | 0.430 |
Why?
|
| Pain, Postoperative | 3 | 2006 | 316 | 0.420 |
Why?
|
| Orthopedic Procedures | 4 | 2016 | 312 | 0.400 |
Why?
|
| Joint Diseases | 3 | 2016 | 113 | 0.360 |
Why?
|
| Hip Prosthesis | 9 | 2016 | 552 | 0.360 |
Why?
|
| Sound Spectrography | 1 | 2010 | 21 | 0.360 |
Why?
|
| Hip Fractures | 1 | 2010 | 26 | 0.350 |
Why?
|
| Middle Aged | 28 | 2021 | 9324 | 0.350 |
Why?
|
| Aged | 27 | 2021 | 9344 | 0.350 |
Why?
|
| Blood Loss, Surgical | 2 | 2007 | 59 | 0.330 |
Why?
|
| Recovery of Function | 8 | 2016 | 300 | 0.320 |
Why?
|
| Radiography | 13 | 2016 | 651 | 0.320 |
Why?
|
| Perioperative Care | 2 | 2006 | 45 | 0.310 |
Why?
|
| Follow-Up Studies | 17 | 2021 | 1864 | 0.310 |
Why?
|
| Male | 30 | 2021 | 15403 | 0.300 |
Why?
|
| Female | 30 | 2021 | 15823 | 0.290 |
Why?
|
| Cementation | 6 | 2021 | 33 | 0.290 |
Why?
|
| Hemostasis, Surgical | 1 | 2007 | 15 | 0.280 |
Why?
|
| Electrocoagulation | 1 | 2007 | 13 | 0.280 |
Why?
|
| Clinical Competence | 2 | 2007 | 248 | 0.280 |
Why?
|
| Polyethylenes | 1 | 2006 | 39 | 0.260 |
Why?
|
| Critical Pathways | 1 | 2006 | 21 | 0.260 |
Why?
|
| Femoral Fractures | 1 | 2006 | 35 | 0.260 |
Why?
|
| Tendon Injuries | 2 | 2005 | 212 | 0.250 |
Why?
|
| Osteolysis | 4 | 2010 | 144 | 0.250 |
Why?
|
| Bone Transplantation | 2 | 2006 | 221 | 0.240 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 52 | 0.230 |
Why?
|
| Lactones | 1 | 2003 | 9 | 0.220 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 27 | 0.220 |
Why?
|
| Isoenzymes | 1 | 2003 | 53 | 0.220 |
Why?
|
| Arthroplasty | 1 | 2004 | 150 | 0.220 |
Why?
|
| Time Factors | 9 | 2011 | 1500 | 0.210 |
Why?
|
| Hip Joint | 5 | 2016 | 549 | 0.210 |
Why?
|
| Adult | 18 | 2019 | 8175 | 0.190 |
Why?
|
| Arthroscopy | 2 | 2016 | 1088 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2009 | 1811 | 0.190 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 36 | 0.190 |
Why?
|
| Osteoarthritis, Hip | 2 | 2016 | 107 | 0.170 |
Why?
|
| Transplantation, Homologous | 3 | 2005 | 286 | 0.160 |
Why?
|
| Biomechanical Phenomena | 4 | 2017 | 676 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2019 | 3614 | 0.150 |
Why?
|
| Patient Selection | 2 | 2014 | 207 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 46 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2016 | 34 | 0.130 |
Why?
|
| Pain Measurement | 4 | 2016 | 472 | 0.130 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2016 | 7 | 0.130 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 9 | 0.130 |
Why?
|
| Braces | 1 | 2016 | 23 | 0.130 |
Why?
|
| Aged, 80 and over | 11 | 2010 | 4901 | 0.130 |
Why?
|
| Joint Instability | 3 | 2016 | 398 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 67 | 0.120 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 23 | 0.120 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2006 | 22 | 0.120 |
Why?
|
| Analgesia, Epidural | 2 | 2006 | 54 | 0.120 |
Why?
|
| Hip Dislocation | 1 | 2016 | 73 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 53 | 0.120 |
Why?
|
| Knee Injuries | 1 | 2016 | 207 | 0.110 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2011 | 24 | 0.110 |
Why?
|
| Bone Cements | 4 | 2009 | 91 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 77 | 0.110 |
Why?
|
| Gait | 1 | 2017 | 412 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2016 | 676 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 180 | 0.100 |
Why?
|
| Orthopedics | 2 | 2005 | 113 | 0.100 |
Why?
|
| Device Removal | 3 | 2009 | 92 | 0.100 |
Why?
|
| Osteotomy | 2 | 2003 | 174 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2014 | 218 | 0.090 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 1 | 0.090 |
Why?
|
| Vibration | 1 | 2010 | 30 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2016 | 1942 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2016 | 433 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2010 | 75 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 264 | 0.080 |
Why?
|
| Probability | 2 | 2004 | 92 | 0.070 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 4 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 990 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2007 | 36 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 155 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2019 | 331 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2006 | 26 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 140 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 36 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2006 | 60 | 0.060 |
Why?
|
| Supine Position | 1 | 2006 | 22 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 74 | 0.060 |
Why?
|
| Medical Laboratory Science | 1 | 2005 | 9 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 233 | 0.060 |
Why?
|
| Nerve Block | 1 | 2006 | 67 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 32 | 0.060 |
Why?
|
| Metals | 1 | 2006 | 152 | 0.060 |
Why?
|
| Decision Trees | 1 | 2005 | 15 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 32 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2004 | 17 | 0.060 |
Why?
|
| Rupture | 1 | 2004 | 114 | 0.060 |
Why?
|
| Physical Therapy Modalities | 1 | 2004 | 75 | 0.060 |
Why?
|
| Weight-Bearing | 1 | 2004 | 171 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 154 | 0.060 |
Why?
|
| Dyssomnias | 1 | 2003 | 6 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 25 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 28 | 0.060 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 16 | 0.060 |
Why?
|
| Sulfones | 1 | 2003 | 20 | 0.060 |
Why?
|
| Disease Progression | 3 | 2016 | 722 | 0.050 |
Why?
|
| Osseointegration | 1 | 2003 | 70 | 0.050 |
Why?
|
| Inhalation | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2003 | 9 | 0.050 |
Why?
|
| Sex Factors | 1 | 2004 | 477 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2003 | 171 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2003 | 46 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 788 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2016 | 125 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 117 | 0.050 |
Why?
|
| Length of Stay | 1 | 2003 | 330 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2003 | 217 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 329 | 0.040 |
Why?
|
| Quality of Life | 1 | 2005 | 659 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 207 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 269 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 132 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 110 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 40 | 0.040 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 21 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 11 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 119 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 21 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 43 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 140 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 507 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 267 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 398 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2004 | 80 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2016 | 332 | 0.020 |
Why?
|
| Risk Factors | 2 | 2010 | 2414 | 0.020 |
Why?
|
| Polymethacrylic Acids | 1 | 2010 | 5 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 248 | 0.020 |
Why?
|
| United States | 2 | 2006 | 2201 | 0.020 |
Why?
|
| Patellofemoral Joint | 1 | 2010 | 66 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 270 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 66 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2007 | 54 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 104 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 95 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 186 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 2006 | 18 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 520 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2005 | 4 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 5 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 22 | 0.020 |
Why?
|
| Porosity | 1 | 2004 | 61 | 0.010 |
Why?
|
| Contraindications | 1 | 2004 | 33 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 30 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 134 | 0.010 |
Why?
|
| Bone Wires | 1 | 2003 | 10 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 129 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 146 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 774 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2003 | 27 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 308 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 51 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 438 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1196 | 0.010 |
Why?
|